article thumbnail

Cholesterol Med, Fenofibrate, Might Slow Vision Loss in People With Diabetes

Drugs.com

Fenofibrate (Tricor) has been approved since 2004 as a means of lowering. TUESDAY, June 25, 2024 -- A well-established cholesterol-lowering drug appears to significantly slow the progression of a diabetes-related eye disease, a new trial shows.

Trials 111
article thumbnail

Cholesterol Med Might Slow Vision Loss in People With Diabetes

Drugs.com

TUESDAY, June 25, 2024 -- A well-established cholesterol-lowering drug appears to significantly slow the progression of a diabetes-related eye disease, a new trial shows.Fenofibrate (Tricor) has been approved since 2004 as a means of lowering.

Trials 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Men's Use of Personal Care Products, and Chemicals They Contain, Has Doubled in 20 Years

Drugs.com

WEDNESDAY, July 26, 2023 -- Men’s use of personal care products has almost doubled since 2004, exposing them to some potentially harmful chemicals, a new study commissioned by the Environmental Working Group (EWG) finds. Overall, the average.

article thumbnail

Clear and Accessible Writing

addgene Blog

In 2004, that was a fairly simple goal… and we had no idea how much our understanding of what accessibility is would change over the next twenty years. Addgene was built on the concept of accessibility: making plasmids more accessible to scientists around the world. But learn we did!

Science 87
article thumbnail

The 3Rs Principles in Cosmetic and Self-care Industry: the Regulation that Prioritises Animal Welfare

biobide

In 2004 the European Union (EU) introduced a ban on animal testing on finished products. Cruelty-free cosmetics have emerged as a powerful statement within the beauty industry and Fast Moving Consumer Goods (FMCG), reflecting a growing consumer consciousness on the ethical treatment of animals.

article thumbnail

UnitedHealthcare CEO Brian Thompson fatally shot in NYC

BioPharma Drive: Drug Pricing

Thompson, 50, had been with UnitedHealth since 2004. The NYPD confirmed the shooting, which caused UnitedHealth to end an investor conference early on Wednesday.

57
article thumbnail

Scrub-a-Dub-Dub: FTC is Cleansing the Orange Book of Device Patents

FDA Law Blog: Biosimilars

Citing to a 2004 Supreme Court case, Verizon Commc’ns., 398 (2004), Teva argued that Amneal has no cause of action under antitrust law because the Hatch-Waxman Amendments impose a new statutory duty on a company to cooperate with competitors and established a remedy for breach of that obligation. of Trinko, LLP , 540 U.S.

FDA 113